| | | This week’s report is a gift to nostalgia buffs, as we are reminded what a week from last year’s contest might look like. In fact it is one of the better ones.
An up-and-down week for the market in general ended down, for the first losing week for the year. The NASDAQ Composite shed -2.4% for the week, matched by the NASDAQ biotech index (-2.6%). The S&P biotech index, which had been significantly outperforming the other biotech index fell more than twice as much (-5.4%). Even with this bad news, the NASDAQ still shows a decent profit (+12%) for the YTD. The Biotech indices’ YTD performance, while still in the black, are feeling much more battered. This week’s loss trimmed more than 70% of the S&P biotech index’s YTD. And the NASDAQ biotech YTD gains have been essentially erased, (+0.3% YTD).
Still as was usually the case last year, even bad weeks can include some individual stocks to cheer about. OMER turned in a gain of +87% of it’s initial price for the week, on the news Monday (https://finance.yahoo.com/news/omeros-corporation-receives-200-million-135000411.html) that it received a $200 million Milestone payment to conclude the sale of their ophthalmology product, Omidria, to Rayner Surgical, while still retaining some royalty rights from future net sales. This performance was enough to move OMER into 3rd place for YTD return (+123%).
The first and third worst performers for the week, INZY (off -38%) and JSPR (-31%) on no particular news, looks like some profit taking on the top YTD performers, rand even these losses were not sufficient to dislodge them from the YTD number 2 (+134%) and number 1 (+270%) positions.
The second worst of the week, PHAT (-34%), seemed to be a reaction to perceived ongoing manufacturing problems, triggered specifically by an FDA formal request for additional data to demonstrate that impurities in their production line found earlier were in fact now controlled.
The contest portfolios were not immune to the general slide for the week, but it was not enough to overcome the great performance during the previous weeks. The average portfolio gave back -$4.4k, but YTD it is in the black by +$21k. Just two portfolios turned a profit for the week, GENEGURU and BULBAMAN, thanks to positions in top performer stocks, DCTH and OMER respectively, but every portfolio is in the black YTD, with even the worst performer is still hanging in their with a profit of +$808 for the year.
The top six YTD performers from the last week have the same positions this week. BLADERUNNER is riding the JSPR tiger, so its loss for the week meant that they had the worst weekly performance of any to the contestants, but not enough to dislodge them from the top spot they’ve occupied since the contest start. It did mean that number two, ALONER, was able to trim $7k from BLADERUNNER’s lead, but ALONER still has another $48k to go to overtake them.
The details of GENEGURU’s portfolio demonstrates their strong performance for the week was, indeed, due to their holding DCTH and GLYC, their only winners for the week. DCTH and GLYC are also the YTD top money makers for GENEGURU.
For BLADERUNNER, all but one of their choices were losses for the week, but none enough to change the fact that YTD every one of their picks are in the black. And even with JSPR’s week to week ping pongs from big profit to big loss for the last three weeks, JSPR's overall YTD ROI of +270% is enough to keep BLADRUNNER in the top spot.
Report Time Ranges
|
|
|
|
|
|
From
|
To
|
|
|
|
|
|
|
|
|
Recent
|
2/3/23
|
2/10/23
|
|
|
|
|
|
|
|
|
YTD
|
12/31/2022
|
|
|
|
|
Index Portfolios’ Performance
|
|
|
|
|
Symbol
|
Recent P/L
|
Recent %
|
YTD P/L
|
|
|
|
|
|
|
|
|
^IXIC
|
-$2,759.62
|
-2.4%
|
$11,958.55
|
|
|
|
|
|
|
|
|
^NBI
|
-$2,627.58
|
-2.6%
|
$298.84
|
|
|
|
|
|
|
|
|
^SPSIBI
|
-$5,806.78
|
-5.4%
|
$2,439.12
|
|
|
|
|
Share Performance
|
Recent Performance
|
YTD Performance
|
|
Top Five
|
|
Bottom Five
|
|
Top Five
|
|
Bottom 5
|
Symbol
|
P/L / Initial Price
|
Symbol
|
P/L / Initial Price
|
Symbol
|
YTD P/L / Initial Price
|
Symbol
|
YTD P/L/ Initial Price
|
OMER
|
86.7%
|
INZY
|
-38.1%
|
JSPR
|
268.5%
|
BCAB
|
-55.8%
|
DCTH
|
41.3%
|
PHAT
|
-34.2%
|
INZY
|
134.3%
|
FATE
|
-38.4%
|
LRMR
|
32.0%
|
JSPR
|
-31.1%
|
OMER
|
123.5%
|
AVTX
|
-37.7%
|
VKTX
|
16.7%
|
IDIA.SW
|
-28.6%
|
CDTX
|
115.5%
|
PDSB
|
-36.4%
|
CDTX
|
15.9%
|
ATRA
|
-27.7%
|
MGTA
|
113.9%
|
GRPH
|
-32.5%
|
Average and Median Portfolio Performance
|
|
Recent P/L
|
|
|
|
YTD P/L
|
|
|
|
Avg.
|
Median
|
|
|
|
Avg
|
Median
|
|
|
|
-$4,458.69
|
-$5,134.20
|
RKRW
|
|
$20,983.60
|
$16,065.03
|
ERIKOTTO
|
Top Seven Portfolio Performances
|
Top Recent Performers
|
Top YTD Performers
|
Contestant (Prev. Rank)
|
Recent P/L
|
P/L vs. ^SPSIBI
|
YTD P/L (Rank)
|
Contestant (Prev. Rank)
|
YTD P/L
|
vs. Top Portfolio
|
P/L vs. ^SPSIBI
|
Rec. P/L (Rank)
|
1 - GENEGURU (12)
|
$5,196.55
|
$11,003.33
|
$5,734.56 (13)
|
1 - BLADERUNNER (1)
|
$82,457.39
|
——
|
$80,018.28
|
-$10,243.47 (15)
|
2 - BULBAMAN (7)
|
$5,187.63
|
$10,994.41
|
$12,995.85 (10)
|
2 - ALONER (2)
|
$34,497.42
|
$47,959.97
|
$32,058.30
|
-$3,294.57 (5)
|
3 - TOMATO (5)
|
-$350.37
|
$5,456.40
|
$18,533.69 (7)
|
3 - STEVE LOKNESS (3)
|
$30,660.10
|
$51,797.29
|
$28,220.99
|
-$6,162.65 (9)
|
4 - BMAZ001 (14)
|
-$3,191.97
|
$2,614.81
|
$2,481.01 (14)
|
4 - JACK HARTMANN (4)
|
$28,123.78
|
$54,333.62
|
$25,684.66
|
-$4,082.31 (7)
|
5 - ALONER (2)
|
-$3,294.57
|
$2,512.21
|
$34,497.42 (2)
|
5 - DEW DILIGENCE (5)
|
$22,774.20
|
$59,683.19
|
$20,335.08
|
-$9,359.96 (14)
|
6 - TECHNETIUM (11)
|
-$3,762.00
|
$2,044.78
|
$12,565.25 (11)
|
6 - RAJU_BIJLEE (6)
|
$19,383.00
|
$63,074.40
|
$16,943.88
|
-$7,668.33 (11)
|
7 - JACK HARTMANN (6)
|
-$4,082.31
|
$1,724.46
|
$28,123.78 (4)
|
7 - TOMATO (9)
|
$18,533.69
|
$63,923.71
|
$16,094.57
|
-$350.37 (3)
|
Top Portfolios’ Contents
|
Top Recent Performance Portfolio (GENEGURU)
|
Top YTD Performance Portfolio (BLADERUNNER)
|
Symbol (Rank)
|
Current Allocation
|
Value/Total | ROI
|
YTD Stock P/L
|
Recent Stock P/L
|
% Current Price Change for $1,000 P/L
|
Symbol (Rank)
|
Initial Allocation
|
Value/Total | ROI
|
YTD Stock P/L
|
Recent Stock P/L
|
% Current Price Change for $1,000 P/L
|
AXSM
|
5.0%
|
3.8% | -18.6%
|
-$929.60
|
-$383.12
|
24.6%
|
CRDF
|
20.0%
|
15.0% | 37.1%
|
$7,428.57
|
-$142.86
|
3.6%
|
CMRX
|
5.0%
|
4.4% | -7.5%
|
-$376.34
|
-$268.82
|
21.6%
|
CRIS
|
15.0%
|
10.9% | 32.0%
|
$4,800.00
|
-$1,472.73
|
5.1%
|
DCTH
|
20.0%
|
27.0% | 42.9%
|
$8,583.33
|
$8,250.00
|
3.5%
|
ENTA
|
5.0%
|
3.1% | 14.0%
|
$700.77
|
$58.04
|
17.5%
|
GLYC
|
20.0%
|
21.7% | 14.9%
|
$2,970.30
|
$2,574.26
|
4.4%
|
IOVA
|
10.0%
|
6.3% | 15.2%
|
$1,518.00
|
-$970.27
|
8.7%
|
INVA
|
5.0%
|
4.4% | -7.5%
|
-$373.58
|
-$203.77
|
21.6%
|
JSPR
|
20.0%
|
40.4% | 268.5%
|
$53,706.00
|
-$6,211.18
|
1.4%
|
MODD
|
5.0%
|
6.0% | 26.5%
|
$1,325.00
|
$0.00
|
15.8%
|
MBIO
|
10.0%
|
9.3% | 69.7%
|
$6,969.62
|
-$22.78
|
5.9%
|
PRQR
|
20.0%
|
14.8% | -21.6%
|
-$4,324.32
|
-$1,351.35
|
6.4%
|
MGTA
|
5.0%
|
5.9% | 113.9%
|
$5,696.20
|
-$150.63
|
9.3%
|
XAIR
|
20.0%
|
17.8% | -5.7%
|
-$1,140.22
|
-$3,420.65
|
5.3%
|
MRSN
|
15.0%
|
9.1% | 10.9%
|
$1,638.23
|
-$1,331.06
|
6.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
